← Back to Search
Blockade Of Nitric Oxide Synthesis Reduces Myocardial Oxygen Consumption In Vivo.
A. J. Sherman, C. A. Davis, F. Klocke, K. Harris, G. Srinivasan, A. Yaacoub, D. Quinn, K. Ahlin, J. Jang
Published 1997 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
BACKGROUND Although cardiac myocytes and coronary vascular endothelium are known to express a constitutive form of NO synthase, the in vivo effects of tonic endogenous production of NO on myocardial O2 consumption and contractile performance remain unclear. METHODS AND RESULTS The effects of blockade of NO synthase were determined in intact dogs. Myocardial O2 consumption decreased systematically over a wide range of hemodynamic demand after the systemic administration of N omega-nitro-L-arginine methyl ester (L-NAME) or N omega-nitro-L-arginine. Decreases after doses of 1 and 10 mg/kg L-NAME averaged 23 +/- 3.8% and 34 +/- 7.2% at a heart rate of 90 bpm in open-chest animals. Similar reductions occurred after the administration of L-NAME and N omega-nitro-L-arginine in chronically instrumented animals and were unaffected by beta-adrenergic blockade. Intracoronary infusion of L-NAME in chronically instrumented animals reduced both myocardial O2 consumption and regional segment shortening, even at a dose that did not increase systemic arterial pressure. CONCLUSIONS The blockade of NO synthesis reduces myocardial O2 consumption in vivo. The decrease in O2 consumption is accompanied by a decrease in segment shortening. It involves a direct myocardial action of NO, is unaffected by beta-blockade, and is consistent with in vitro studies indicating that low levels of NO augment contractile performance by inhibition of a cGMP-dependent phosphodiesterase.
This paper references
Myocardial Oxygen Consumption in Acute Experimental Cardiac Depression
T. Graham (1967)
Potentiation by cyclic GMP of beta‐adrenergic effect on Ca2+ current in guinea‐pig ventricular cells.
K. Ono (1991)
Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
A. Chu (1991)
Negative inotropic effects of cytokines on the heart mediated by nitric oxide.
M. Finkel (1992)
Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs.
R. Parent (1992)
NG-methyl-L-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitro.
R. Klabunde (1992)
Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia.
A. Brady (1992)
Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart.
M. Amrani (1992)
Role of endothelium-derived relaxing factor in parasympathetic coronary vasodilation.
T. Broten (1992)
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
J. Balligand (1993)
NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists.
I. L. Buxton (1993)
Modulation of coronary autoregulatory responses by nitric oxide. Evidence for flow-dependent resistance adjustments in conscious dogs.
T. P. Smith (1993)
Nitric oxide attenuates cardiac myocyte contraction.
A. Brady (1993)
Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.
J. Balligand (1993)
Role of nitric oxide in the regulation of oxygen consumption in conscious dogs.
W. Shen (1994)
Role of endothelium-derived nitric oxide and adenosine in functional myocardial hyperemia
K. Maekawa (1994)
Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis.
D. Duncker (1994)
Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle.
A. Weyrich (1994)
Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog.
J. Altman (1994)
8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes.
A. Shah (1994)
Nitric Oxide Does Not Mediate Coronary Vasodilation by Isoflurane
G. Crystal (1994)
Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts.
K. A. Kirkebøen (1994)
Nitric oxide regulates the calcium current in isolated human atrial myocytes.
M. Kirstein (1995)
Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
J. Gurevicius (1995)
Nitric Oxide-dependent Parasympathetic Signaling Is Due to Activation of Constitutive Endothelial (Type III) Nitric Oxide Synthase in Cardiac Myocytes (*)
J. Balligand (1995)
Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption.
W. Shen (1995)
Paracrine coronary endothelial control of left ventricular function in humans.
W. Paulus (1995)
Nitric oxide is an important determinant of coronary flow at rest and during hypoxemic stress in fetal lambs.
M. Reller (1995)
Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs.
J. Hare (1995)
Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.
M. Finkel (1995)
Inhibition of nitric oxide synthesis reduces coronary blood flow response but does not increase cardiac contractile response to beta-adrenergic stimulation in normal dogs.
H. Kaneko (1996)
Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes.
G. Kojda (1996)
Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes.
D. Kaye (1996)
Myocardial contractile response to nitric oxide and cGMP.
P. Mohan (1996)
This paper is referenced by
Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension
P. Stanko (2020)
Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.
H. Taegtmeyer (2016)
consumption in anesthetized dogs Nitric oxide does not modulate whole body oxygen
Xiping Zhou (2015)
Redox-mediated programed death of myocardial cells after cardiac arrest and cardiopulmonary resuscitation
A. Chalkias (2012)
Nitric oxide signaling in the microcirculation.
D. Buerk (2011)
What is the real physiological NO concentration in vivo?
C. Hall (2009)
Enhancer AVE9488 After Experimental Myocardial Infarction Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase
F. Spinale (2008)
Significance of nitric oxide metabolites in the human circulation in health and disease
A. Khalatbari (2008)
Increase in exhaled nitric oxide and protective role of the nitric oxide system in experimental pulmonary embolism
K. Nilsson (2007)
Cardiomyocytes as effectors of nitric oxide signalling.
M. Seddon (2007)
Nitric oxide regulation of mitochondrial oxygen consumption II: Molecular mechanism and tissue physiology.
C. Cooper (2007)
Phenotypic adaptation of the late preconditioned heart: myocardial oxygen consumption is reduced.
X. Monnet (2006)
Nitric oxide regulation of myocardial O2 consumption and HEP metabolism.
J. Zhang (2005)
Endothelial Nitric Oxide Synthase in Cardiovascular Homeostasis and Disease
D. Duncker (2004)
Triggers and mediators of acute exercise-induced cardioprotection
R. P. Taylor (2004)
S-Nitroso Human Serum Albumin Improves Oxygen Metabolism during Reperfusion after Severe Myocardial Ischemia
M. Dworschak (2004)
Nitric oxide synthase inhibition with l‐NAME reduces maximal oxygen uptake but not gas exchange threshold during incremental cycle exercise in man
A. Jones (2004)
Insulin-Stimulated Myocardial Glucose Uptake and the Relation to Perfusion and the Nitric Oxide System
H. Søndergaard (2004)
Endothelial NO formation does not control myocardial O2 consumption in mouse heart.
Z. Kojić (2003)
THE CARDIOTOXICITY OF CARBON MONOXIDE
A. P. Patel (2003)
Coronary blood flow regulation in exercising swine involves parallel rather than redundant vasodilator pathways.
D. Merkus (2003)
Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.
D. Brutsaert (2003)
Nitric Oxide and Fetal Coronary Regulation
K. Thornburg (2002)
Nitric Oxide Modulates Myocardial Oxygen Consumption in the Failing Heart
Y. Chen (2002)
Regulation of the rate of synthesis of nitric oxide by Mg2+ and hypoxia. Studies in rat heart mitochondria
S. Manzo-Ávalos (2002)
Inhibition of NO production increases myocardial blood flow and oxygen consumption in congestive heart failure.
J. Traverse (2002)
Adrenomedullin and Nitrite Levels in Children with Dilated Cardiomyopathy
M. Kilinç (2002)
Endogenous nitric oxide enhances coupling between O2 consumption and ATP synthesis in guinea pig hearts.
W. Shen (2001)
Nitric oxide reduces energy supply by direct action on the respiratory chain in isolated cardiomyocytes.
T. Stumpe (2001)
Nitric oxide donor FK409 and 8‐bromoguanosine‐cyclic monophosphate attenuate cardiac contractility assessed by Emax
H. Hiraga (2001)
Bovine polymerized hemoglobin increases cardiac oxygen consumption and alters myocardial substrate metabolism in conscious dogs: role of nitric oxide.
K. Loke (2000)
Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy.
T. Shinke (2000)See more